Lincoln Pharmaceuticals Ltd (LPL) on 7 February 2011 announced the launch of India's first long-acting paracetamol product, Pa 12. Pa 12 is a medicine for long-term relief from fever and pain. Though it is a medicine provided on a prescription, it will also be available over-the-counter (OTC) with a shelf-life of three years. Pa 12 has been programmed for non-stop service with a 1000 mg tablet for 12-hour-long relief. In Pa, 300 mg of paracetamol is released for prompt symptomatic relief and the remaining 700 mg is meant for sustained release over 12 hours for non-stop therapeutic action. With the launch of Pa 12 LPL is targeting a 10-15 per cent market in the first year, out of the Rs 250-crore worth of market size in India for the prescribed paracetamol products.
LPL is present in 25 countries, mainly in the semi-regulated markets of Africa, South East Asia and Latin America where it has registered nearly 300 products.
Comments
All Comments (0)
Join the conversation